Form 4: Mirum Pharmaceuticals Director William Fairey Sells 3,203 Shares
SEC Form 4 Filing
William Fairey, a director at Mirum Pharmaceuticals, sold 3,203 shares of common stock at a price of $48.4204 on June 11, 2025.
Summary
- On June 11, 2025, William Fairey, a director of Mirum Pharmaceuticals, Inc., sold 3,203 shares of common stock.
- The transaction was executed at a price of $48.4204 per share.
- Following the transaction, Mr. Fairey directly owns 2,500 shares of Mirum Pharmaceuticals.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing reporting a stock sale by a company director. It doesn't inherently convey positive or negative sentiment.
Future Outlook
No future outlook provided in this document.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to the market regarding the trading activities of company directors.
Stakeholder Impact
- Shareholders: The transaction provides transparency regarding insider trading activity.
- Potential Investors: The transaction may be relevant for assessing insider sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/11/2025 | Date of transaction: William Fairey sold shares of common stock. |
| 06/12/2025 | Date of signature by Attorney-in-Fact. |
Keywords
Mirum Pharmaceuticals, William Fairey, stock sale, Form 4, director, MIRM, SEC filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.